“To Fix a Broken Heart”: An Unusual Case of Infective Endocarditis Involving the Mitral Valve With Perforation and Hemodynamic Instability

Abstract

Infective endocarditis (IE), commonly caused by Staphylococcus aureus, can affect multiple cardiac structures and lead to significant morbidity and mortality. We present a case of IE with extensive mitral valve involvement causing perforation and hemodynamic compromise.A 66-year-old Caucasian female presented to the emergency department for progressive altered mental status and lethargy. The patient and family denied history of intravenous drug use (IVDU) on interview. Physical exam revealed tachypnea, tachycardia, lethargy, and fluctuance in the right antecubital fossa draining serous fluid. Initial studies revealed a urinary tract infection, patchy bilateral opacities on chest xray, hypoxic respiratory failure, elevated lactate and cardiac markers, leukocytosis, and positive urine toxicology for opioid and benzodiazepine. She was intubated and admitted to the ICU, and later developed acute respiratory distress syndrome with requirement for vasopressors. Antibiotics were started, and blood cultures ultimately grew methicillin-sensitive S. aureus. Coronavirus disease 2019 (COVID-19) results were negative. Cardiology was consulted for elevated cardiac markers that were due to myocardial injury in the setting of septic shock. A transthoracic echocardiogram showed a large mobile mass on the anterior mitral leaflet. Further evaluation with transesophageal echocardiogram revealed a large, mobile, and centrally necrotic vegetation on the medial portion of the mitral annulus extending to both the anterior and posterior leaflets. Doppler of the valve showed holosystolic retrograde ejection into the left atrium confirming a perforation. The patient was transferred urgently to a cardiothoracic surgery capable center for operative intervention on the mitral valve.IE is most commonly caused by S. aureus and seen in highest rates among patients with a prosthetic valve, congenital heart disease, and intracardiac device. However, roughly 50% of IE occurs in patients without any valvular disease. Other risk factors include IVDU, valvular disease, and prior history of endocarditis. Clinical diagnosis of IE is made using the Duke's criteria, with echocardiogram and bacteremia playing a major role. The initial management involves empiric antibiotics until a pathogen is identified. Surgical consult is also suggested, and indications for surgery include heart failure due to valve dysfunction, uncontrolled infection, prevention of embolism, and hemodynamic compromise. Prompt recognition and intervention is crucial in the prevention of mortality in patients with IE leading to mitral perforation and hemodynamic compromise.

Fungal Endocarditis Secondary to Transdermal Fentanyl Patch

“…As a result of an infection entering the bloodstream, traveling to the heart, and infiltrating coronary tissue, infectious endocarditis (IE) is mostly caused by Staphylococcus aureus [ 1 ]. The possible entrance points are dental work, urinary tract infections, lung infections, gastrointestinal infections, skin conditions, intravenous drug use, surgery, and intravenous cannulation from hospital admissions [ 2 ].…”

Blood Culture-Negative Endocarditis Secondary to Skin Popping

“…An infection that enters the bloodstream, travels to the heart, and infiltrates coronary tissue is what causes infectious endocarditis (IE); with the most frequent cause of the disease being Staphylococcus aureus [ 1 ]. Around 5% of the general population is at risk for developing IE, making it a prevalent illness [ 2 ].…”

COVID-19-associated MRSA infective endocarditis and mitral valve perforation: a case report

“…The most common causative agent is Staphylococcus aureus, which can lead to complications such as emboli and abscesses in distant organs such as the central nervous system, spleen, kidneys, or skin. IE has a high mortality and morbidity rate due to the risk of embolic phenomena [ 1 , 2 ].…”